Compare J.B.Chemicals with Sun Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs SUN PHARMA - Comparison Results

J.B.CHEMICALS     Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

SUN PHARMA 
   Change

Sun Pharma holds 3.7% share of the domestic pharma market (as per the latest ORG IMS MAT data) and has a strong presence in the lifestyle therapeutic segments. The company started focusing on the exports market in FY02, when it increased its stake to... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS SUN PHARMA J.B.CHEMICALS/
SUN PHARMA
 
P/E (TTM) x 16.7 28.3 58.9% View Chart
P/BV x 2.3 2.4 94.3% View Chart
Dividend Yield % 0.5 0.7 78.1%  

Financials

 J.B.CHEMICALS   SUN PHARMA
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-18
SUN PHARMA
Mar-19
J.B.CHEMICALS/
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs363679 53.5%   
Low Rs255375 67.9%   
Sales per share (Unadj.) Rs169.1121.1 139.6%  
Earnings per share (Unadj.) Rs16.613.4 124.1%  
Cash flow per share (Unadj.) Rs23.420.7 113.2%  
Dividends per share (Unadj.) Rs2.002.75 72.7%  
Dividend yield (eoy) %0.60.5 124.0%  
Book value per share (Unadj.) Rs172.5172.6 99.9%  
Shares outstanding (eoy) m83.572,399.26 3.5%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x1.84.4 42.0%   
Avg P/E ratio x18.639.4 47.2%  
P/CF ratio (eoy) x13.225.5 51.8%  
Price / Book Value ratio x1.83.1 58.7%  
Dividend payout %12.020.6 58.6%   
Avg Mkt Cap Rs m25,8271,264,650 2.0%   
No. of employees `0003.817.5 21.6%   
Total wages/salary Rs m2,51159,671 4.2%   
Avg. sales/employee Rs Th3,747.416,608.1 22.6%   
Avg. wages/employee Rs Th665.73,409.6 19.5%   
Avg. net profit/employee Rs Th367.81,833.8 20.1%   
INCOME DATA
Net Sales Rs m14,135290,659 4.9%  
Other income Rs m36610,255 3.6%   
Total revenues Rs m14,501300,914 4.8%   
Gross profit Rs m2,17863,076 3.5%  
Depreciation Rs m57017,533 3.2%   
Interest Rs m355,553 0.6%   
Profit before tax Rs m1,94050,246 3.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-12,144 0.0%   
Tax Rs m5526,009 9.2%   
Profit after tax Rs m1,38732,093 4.3%  
Gross profit margin %15.421.7 71.0%  
Effective tax rate %28.512.0 238.1%   
Net profit margin %9.811.0 88.9%  
BALANCE SHEET DATA
Current assets Rs m10,470310,692 3.4%   
Current liabilities Rs m2,749173,396 1.6%   
Net working cap to sales %54.647.2 115.6%  
Current ratio x3.81.8 212.6%  
Inventory Days Days5599 55.7%  
Debtors Days Days78112 69.6%  
Net fixed assets Rs m5,811232,477 2.5%   
Share capital Rs m1672,399 7.0%   
"Free" reserves Rs m14,248411,691 3.5%   
Net worth Rs m14,416414,091 3.5%   
Long term debt Rs m015,226 0.0%   
Total assets Rs m17,649646,938 2.7%  
Interest coverage x56.610.0 563.0%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.80.4 178.3%   
Return on assets %8.15.8 138.5%  
Return on equity %9.67.8 124.2%  
Return on capital %13.710.2 134.7%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m6,16466,025 9.3%   
Fx outflow Rs m1,33438,610 3.5%   
Net fx Rs m4,82927,415 17.6%   
CASH FLOW
From Operations Rs m1,23121,965 5.6%  
From Investments Rs m-208-6,813 3.1%  
From Financial Activity Rs m-595-27,305 2.2%  
Net Cashflow Rs m427-8,442 -5.1%  

Share Holding

Indian Promoters % 55.4 63.7 87.0%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 3.4 5.1 66.1%  
FIIs % 3.9 23.0 17.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 8.3 445.8%  
Shareholders   30,437 133,026 22.9%  
Pledged promoter(s) holding % 0.0 0.5 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   ELDER PHARMA  FDC LTD.  ORCHID PHARMA LTD  DISHMAN PHARMA  TTK HEALTHCARE  

Compare J.B.CHEMICALS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Continue Downtrend, Developments From the IPO Space, and Top Cues in Focus Today(Pre-Open)

On Tuesday, Indian share markets fell sharply during closing hours amid fears of rising crude oil prices and weakness in the rupee.

Related Views on News

SUN PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 35.3% (Quarterly Result Update)

Aug 14, 2019 | Updated on Aug 14, 2019

For the quarter ended June 2019, SUN PHARMA has posted a net profit of Rs 15 bn (up 35.3% YoY). Sales on the other hand came in at Rs 84 bn (up 15.9% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

Here's an analysis of the annual report of SUN PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

SUN PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 53.4% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, SUN PHARMA has posted a net profit of Rs 7 bn (down 53.4% YoY). Sales on the other hand came in at Rs 72 bn (up 2.7% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

J.B.CHEMICALS Announces Quarterly Results (4QFY19); Net Profit Up 91.2% (Quarterly Result Update)

May 24, 2019 | Updated on May 24, 2019

For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

J.B.CHEMICALS 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of J.B.CHEMICALS for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of J.B.CHEMICALS. Also includes updates on the valuation of J.B.CHEMICALS.

More Views on News

Most Popular

Buying these Eight Stocks is Like Owning Your Own Business(Profit Hunter)

Sep 5, 2019

Everyone dreams of owning a business. Here is your chance.

7 Stocks to Buy in the Market Today(The 5 Minute Wrapup)

Sep 5, 2019

The stock market had a four-year bull run starting September 2013. Are we seeing a similar pattern now?

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

This Company Will Do Well Despite the Slowdown(The 5 Minute Wrapup)

Sep 11, 2019

How financial inclusion provides a big runway for this stock recommendation.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Sep 17, 2019 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS 5-YR ANALYSIS

COMPARE J.B.CHEMICALS WITH

MARKET STATS